Bioceltix Balance Sheet Health

Financial Health criteria checks 6/6

Bioceltix has a total shareholder equity of PLN44.9M and total debt of PLN0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are PLN52.0M and PLN7.1M respectively.

Key information

0%

Debt to equity ratio

zł0

Debt

Interest coverage ration/a
Cashzł20.04m
Equityzł44.89m
Total liabilitieszł7.12m
Total assetszł52.01m

Recent financial health updates

Recent updates

We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

Jun 15
We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

Will Bioceltix (WSE:BCX) Spend Its Cash Wisely?

Jan 19
Will Bioceltix (WSE:BCX) Spend Its Cash Wisely?

We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

Sep 21
We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

May 09
We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

Financial Position Analysis

Short Term Liabilities: BCX's short term assets (PLN50.3M) exceed its short term liabilities (PLN7.0M).

Long Term Liabilities: BCX's short term assets (PLN50.3M) exceed its long term liabilities (PLN139.9K).


Debt to Equity History and Analysis

Debt Level: BCX is debt free.

Reducing Debt: BCX had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BCX has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: BCX has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 47.5% each year.


Discover healthy companies